Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.

MIT researchers can now track a cell’s RNA expression to investigate long-term processes like cancer progression or embryonic development.

The COVID-19 pandemic demonstrated the promise of using mRNA as medicine. But before mRNA drugs can go beyond vaccines, researchers need to identify the right diseases to treat.

MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.

From COVID-19 vaccines to cancer treatments and beyond, the flexibility of mRNA-based therapies gives them the potential to prevent and treat many types of diseases.

When just one of the thousands of microRNAs in people go awry, it can cause diseases ranging from heart disease to cancer.

By analyzing bacterial data, researchers have discovered thousands of rare new CRISPR systems that have a range of functions and could enable gene editing, diagnostics, and more.

A new device that "listens in" on cell conversations could lead to quicker, minimally invasive diagnoses for cancer and other diseases.

New research finds RNA-guided enzymes called Fanzors are widespread among eukaryotic organisms.

The human body has been making antivirals for eons, long before scientists did. A protein in your cells called viperin produces molecules that work similarly to the COVID-19 antiviral remdesivir.